{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:24:14Z","timestamp":1792023854223,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","heartrhythmjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.hrthm.2019.09.019","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T08:47:10Z","timestamp":1572338830000},"page":"e373-e407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary"],"prefix":"10.1016","volume":"16","author":[{"given":"Jeffrey A.","family":"Towbin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco C.C.","family":"Darrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Daubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"de Chillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene C.","family":"DePasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind Y.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"N.A. Mark","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Indik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Ingles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank I.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Mestroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia G.","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Saffitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayan","family":"Sanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"van Tintelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2019.09.019_bib1","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.hrthm.2017.06.039","article-title":"HRS Clinical Document Development Methodology Manual and Policies: Executive summary","volume":"14","author":"Indik","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIR.0000000000000312","article-title":"Further Evolution of the ACC\/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"133","author":"Halperin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib3","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2008.04.014","article-title":"ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities","volume":"5","author":"Epstein","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib6","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib7","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib8","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib10","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2019.09.019_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia: An International Task Force Consensus Statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib13","doi-asserted-by":"crossref","first-page":"H1313","DOI":"10.1152\/ajpheart.00816.2005","article-title":"Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures","volume":"290","author":"Hoshijima","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCEP.109.927202","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy diagnostic task force criteria: impact of new task force criteria","volume":"3","author":"Cox","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib15","doi-asserted-by":"crossref","first-page":"f3","DOI":"10.1093\/europace\/eux202","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: an electrocardiogram-based review","volume":"20","author":"Nunes de Alencar Neto","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.09.019_bib16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hrthm.2019.09.019_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.09.019_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1329","article-title":"ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating","volume":"36","author":"Bienengraeber","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/344208","article-title":"Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy","volume":"71","author":"Rampazzo","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.110.005405","article-title":"Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes","volume":"124","author":"Taylor","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/eurheartj\/ehs373","article-title":"Mutations in the area composita protein alphaT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy","volume":"34","author":"van Hengel","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/jce.13621","article-title":"Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)","volume":"29","author":"Murray","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib23","first-page":"1063","article-title":"Arrhythmogenic right ventricular cardiomyopathy: implications of next-generation sequencing in appropriate diagnosis","volume":"19","author":"Medeiros-Domingo","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.09.019_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001605","article-title":"Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"10","author":"Mayosi","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/chd.12462","article-title":"Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy","volume":"12","author":"Turkowski","year":"2017","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hrthm.2019.09.019_bib26","doi-asserted-by":"crossref","first-page":"e002123","DOI":"10.1161\/CIRCGEN.118.002123","article-title":"Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy","volume":"11","author":"De Bortoli","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.hrthm.2019.09.019_bib27","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2010.12.036","article-title":"Distinguishing arrhythmogenic right ventricular cardiomyopathy\/dysplasia-associated mutations from background genetic noise","volume":"57","author":"Kapplinger","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2011.01.016","article-title":"Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy","volume":"88","author":"Norton","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib29","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ejhg.2012.39","article-title":"Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7 is caused by a DES mutation","volume":"20","author":"Hedberg","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/509122","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2","volume":"79","author":"Syrris","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/504393","article-title":"DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"79","author":"Awad","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.RES.0000241482.19382.c6","article-title":"Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"99","author":"Yang","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.09.019_bib33","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/hmg\/9.18.2761","article-title":"Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma","volume":"9","author":"Norgett","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib34","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib35","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1086\/521633","article-title":"A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy","volume":"81","author":"Asimaki","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib36","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","article-title":"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)","volume":"355","author":"McKoy","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib37","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.jacc.2003.10.021","article-title":"Mutations in Cypher\/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction","volume":"42","author":"Vatta","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","article-title":"Mutations in the Lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy","volume":"33","author":"Quarta","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(04)00405-2","article-title":"Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block","volume":"117","author":"Pashmforoush","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2019.09.019_bib40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ng1461","article-title":"Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Gerull","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.hrthm.2019.09.019_bib42","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.09.019_bib43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","article-title":"Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy","volume":"54","author":"Brauch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib44","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","article-title":"SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia","volume":"110","author":"McNair","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib46","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","article-title":"Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria","volume":"123","author":"Quarta","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0004.2012.01919.x","article-title":"The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43","volume":"83","author":"Hodgkinson","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib48","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.hrthm.2009.07.041","article-title":"Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene","volume":"6","author":"van Tintelen","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/eurheartj\/ehv387","article-title":"Approach to family screening in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"37","author":"Te Riele","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib52","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.hrthm.2011.06.026","article-title":"Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations","volume":"8","author":"Bauce","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy Patients and Family Members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib54","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jacc.2006.06.045","article-title":"Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"48","author":"Dalal","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib55","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0735-1097(02)02307-0","article-title":"Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy\/dysplasia reveals a need to broaden diagnostic criteria","volume":"40","author":"Hamid","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2014.04.044","article-title":"Yield of serial evaluation in at-risk family members of patients with ARVD\/C","volume":"64","author":"te Riele","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/europace\/euv061","article-title":"Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy","volume":"18","author":"Protonotarios","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.09.019_bib58","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2013.04.084","article-title":"Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy","volume":"62","author":"Perrin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib59","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib60","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/01.CIR.0000143375.93288.82","article-title":"Natural history and risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"110","author":"Hulot","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment","volume":"64","author":"Link","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib62","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006242","article-title":"Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications","volume":"6","author":"Orgeron","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2019.09.019_bib63","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jacc.2004.08.068","article-title":"The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)","volume":"45","author":"Hodgkinson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.09.019_bib65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib66","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib67","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.09.019_bib68","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.09.019_bib69","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.09.019_bib70","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib71","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib72","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.jacc.2016.09.951","article-title":"Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk","volume":"68","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib73","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/eurheartj\/ehr040","article-title":"Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry","volume":"32","author":"Pinamonti","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib74","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib75","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacep.2016.02.019","article-title":"Potentially Lethal Ventricular Arrhythmias and Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy: What Are the Differences Between Men and Women?","volume":"2","author":"Kimura","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib76","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib77","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/europace\/eul053","article-title":"Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"8","author":"Wlodarska","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.09.019_bib78","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2013.03.087","article-title":"Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy)","volume":"62","author":"Ruwald","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib79","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry","volume":"54","author":"Marcus","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.hrthm.2019.09.019_bib81","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.hrthm.2016.12.010","article-title":"Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"14","author":"Ermakov","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib82","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter ablation of ventricular tachycardia in nonischemic heart disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.09.019_bib84","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib85","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.hrthm.2017.03.008","article-title":"Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group","volume":"14","author":"Tzou","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib86","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib87","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.hrthm.2010.12.015","article-title":"Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease","volume":"8","author":"Mallidi","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib88","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hrthm.2014.12.018","article-title":"Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Philips","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","article-title":"Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation","volume":"4","author":"Bai","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib90","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/europace\/eux056","volume":"19","author":"Berruezo","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.09.019_bib91","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","article-title":"Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Dalal","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib92","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib93","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.181","article-title":"Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members","volume":"16","author":"Saberniak","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.09.019_bib94","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib95","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacep.2015.08.004","article-title":"Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset Disease","volume":"1","author":"Te Riele","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib96","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrthm.2015.08.035","article-title":"Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers","volume":"13","author":"Sawant","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib97","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib98","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/CIRCULATIONAHA.106.660241","article-title":"Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy provides novel insights into patterns of disease expression","volume":"115","author":"Sen-Chowdhry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib99","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"2011 Compendium of Physical Activities: a second update of codes and MET values","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.hrthm.2019.09.019_bib100","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.cir.0000435708.67487.da","article-title":"Guide to the assessment of physical activity: Clinical and research applications: a scientific statement from the American Heart Association","volume":"128","author":"Strath","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib101","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jacep.2018.01.010","article-title":"Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy","volume":"4","author":"Lie","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib102","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00695078","article-title":"The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden","volume":"402","author":"Eriksson","year":"1984","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib104","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1540-8159.1984.tb05599.x","article-title":"Pacemaker treatment in familial amyloidosis with polyneuropathy","volume":"7","author":"Eriksson","year":"1984","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib105","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib106","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13506129.2018.1449744","article-title":"Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?","volume":"25","author":"Muchtar","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.hrthm.2019.09.019_bib107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjh.14747","article-title":"Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis","volume":"182","author":"Rezk","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib108","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/jce.13046","article-title":"Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis","volume":"27","author":"Tan","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib109","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCGENETICS.109.903898","article-title":"The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy","volume":"3","author":"Hoedemaekers","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.hrthm.2016.11.014","article-title":"Ventricular arrhythmias associated with left ventricular noncompaction: Electrophysiologic characteristics, mapping, and ablation","volume":"14","author":"Muser","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.09.019_bib111","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001735","article-title":"Genetic Testing in Pediatric Left Ventricular Noncompaction","volume":"10","author":"Miller","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.09.019_bib112","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1540-8167.2011.02015.x","article-title":"Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy","volume":"22","author":"Caliskan","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib113","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.amjcard.2011.05.039","article-title":"Frequency of stroke and embolism in left ventricular hypertrabeculation\/noncompaction","volume":"108","author":"Stollberger","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib114","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.113.002511","article-title":"Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center","volume":"127","author":"Brescia","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehm481","article-title":"Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?","volume":"29","author":"Kohli","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.09.019_bib116","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.amjcard.2017.07.103","article-title":"Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR((R)) Implantable Cardioverter-Defibrillator Registry)","volume":"120","author":"Gleva","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib117","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCULATIONAHA.114.008554","article-title":"Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations","volume":"130","author":"Gati","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib118","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2016.08.053","article-title":"Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study","volume":"68","author":"Andreini","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib119","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006174","article-title":"Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging","volume":"10","author":"Ivanov","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2019.09.019_bib120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RTI.0b013e31828e9b3d","article-title":"Defining left ventricular noncompaction using cardiac computed tomography","volume":"29","author":"Sidhu","year":"2014","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.hrthm.2019.09.019_bib121","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.CIR.82.2.507","article-title":"Isolated noncompaction of left ventricular myocardium. A study of eight cases","volume":"82","author":"Chin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.09.019_bib122","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/heart.86.6.666","article-title":"Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy","volume":"86","author":"Jenni","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.09.019_bib123","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0002-9149(02)02723-6","article-title":"Left ventricular hypertrabeculation\/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders","volume":"90","author":"Stollberger","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib124","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2005.03.045","article-title":"Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging","volume":"46","author":"Petersen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.09.019_bib125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.acvd.2010.01.002","article-title":"Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography","volume":"103","author":"Thuny","year":"2010","journal-title":"Archives of cardiovascular diseases"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119308525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119308525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T15:41:04Z","timestamp":1572363664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527119308525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":125,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1547527119308525"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.09.019","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}